Taisho Pharmaceutical Co., Ltd.

Toyama Chemical Co., Ltd.

Mitsubishi Chemical Corporation

Mitsubishi Rayon Company, Limited

Fujifilm Toyama Chemical Co., Ltd.

Yusuke Oka

Tetsuya Yabuuchi

Yoshinori Sekiguchi

Shoichi Kuroda

Fumito Uneuchi

Nobuyuki Yamamoto

Masato Takahashi

Naoya Ono

Takahiro Oi

Hiroki Urabe

Tetsuo Takayama

Hajime Takashima

Hironori Kotsubo

Muneo Shoji

Yasuko Kawaguchi

Risa Tsuruta

Yoichiro Suga

Atsushi Kawamura

Hiroshi Inagaki

Hajime Asanuma

Fumihito Ushiyama

Madoka Kawamura

Daisuke Wakasugi

Takeshi Koami

Yoshihisa Shirasaki

Akito Hatayama

Rie Nishikawa

A heat treatment furnace device for heat-treating precursor fiber bundles of carbon fibers, having: a heat treatment chamber, in which continuously supplied precursor fiber bundles are treated with hot air, a hot air circulation path, through which hot air from the heat treatment chamber returns to the heat treatment chamber, and a condensation/separation device, into which the hot air flowing through the hot air circulation path is introduced and separated into a condensate and a gas; wherein the condensation/separation device has: a condensation treatment chamber and a condensation unit, which is provided in the condensation treatment chamber and has condensation surfaces on which the condensate is formed and allowed to drip down.

Heat treatment furnace device and method for producing carbon fiber bundle

Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria includingand its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof. 

Hydroxamic acid derivative

Provided is a carbonization furnace in which disordering of fiber bundles does not occur and there is no lack of uniformity throughout the entire furnace interior, even in the supply of heated inert gas. A carbonization furnace for manufacturing carbon fiber bundles, the furnace being provided with a heat treatment chamber, an inlet sealed chamber and an outlet sealed chamber, a gas spray nozzle, and a conveyance path, wherein: the gas spray nozzle () has a double tube structure obtained from a hollow cylindrical inner tube () and a hollow cylindrical outer tube (), and is disposed in a direction that is horizontal and is orthogonal to the fiber bundle conveyance direction; in the outer tube, multiple gas-spraying holes () are disposed across the width of the conveyance path in the longitudinal direction of the outer tube, and the area of the gas-spraying holes of the outer tube is 0.5 mm2 to 20 mm2; in the inner tube, multiple gas-spraying holes () are disposed across the width of the conveyance path in the longitudinal direction of the inner tube such that the gas-spraying directions of the gas-spraying holes are in two or more directions of the circumferential direction of the inner tube, and the interval of the gas-spraying holes of the inner tube in the longitudinal direction of the inner tube is 300 mm or less.

Carbonization furnace for manufacturing carbon fiber bundle and method for manufacturing carbon fiber bundle

Provided are novel compounds that bind to FKBP12 or pharmaceutically acceptable salts thereof, as well as new therapeutics useful in the prevention or treatment of alopecia which comprise those compounds or pharmaceutically acceptable salts thereof. Specifically, compounds represented by formula (1) [where Rrepresents either the following formula (2) or (3)] or pharmaceutically acceptable salts thereof are provided.

Azole derivative

Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria includingand its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof: 

A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase &#x3b3; inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.

Aminothiazole derivative

A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

Isoquinoline derivative

Growing community of inventors

Tokyo, Japan

Yusuke Oka